USA - NASDAQ:SIGA - US8269171067 - Common Stock
SIGA gets a fundamental rating of 8 out of 10. The analysis compared the fundamentals against 195 industry peers in the Pharmaceuticals industry. SIGA scores excellent points on both the profitability and health parts. This is a solid base for a good stock. A decent growth rate in combination with a cheap valuation! Better keep an eye on SIGA. With these ratings, SIGA could be worth investigating further for value and quality investing!.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 34.92% | ||
ROE | 39.26% | ||
ROIC | 36.93% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 56.25% | ||
PM (TTM) | 45.75% | ||
GM | 76.92% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Altman-Z | 16.95 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 10.09 | ||
Quick Ratio | 8.52 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 7.39 | ||
Fwd PE | 5.15 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 5.02 | ||
EV/EBITDA | 4.14 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 7.3% |
8.35
-0.07 (-0.83%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 7.3% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 7.39 | ||
Fwd PE | 5.15 | ||
P/S | 3.33 | ||
P/FCF | 5.02 | ||
P/OCF | 5.02 | ||
P/B | 2.86 | ||
P/tB | 2.87 | ||
EV/EBITDA | 4.14 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 34.92% | ||
ROE | 39.26% | ||
ROCE | 47.53% | ||
ROIC | 36.93% | ||
ROICexc | 260.41% | ||
ROICexgc | 268.41% | ||
OM | 56.25% | ||
PM (TTM) | 45.75% | ||
GM | 76.92% | ||
FCFM | 66.25% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Debt/EBITDA | 0 | ||
Cap/Depr | 12.22% | ||
Cap/Sales | 0.04% | ||
Interest Coverage | 250 | ||
Cash Conversion | 117.21% | ||
Profit Quality | 144.82% | ||
Current Ratio | 10.09 | ||
Quick Ratio | 8.52 | ||
Altman-Z | 16.95 |